6/25/2015 | HYLM | Biomet calls two series of 6½% notes due 2020 after acquisition closes
|
5/27/2015 | HYLM | Biomet to redeem two series of 6½% notes due 2020 after LVB’s merger
|
1/6/2015 | BKBWHY | Biomet ends fiscal Q2 with net debt of $5.44 billion, readies for Zimmer Holdings closing
|
7/2/2014 | BKHY | S&P: Biomet on positive watch after merger news
|
4/30/2014 | BKIG | Zimmer gets commitment from Credit Suisse for $12.01 billion loans
|
4/24/2014 | BK | Market Commentary: Interactive Data, Hearthside, Pier 1, Hi-Crush, Campaign Monitor break; Biomet up on buyout
|
4/24/2014 | BKHY | Moody's might lift Biomet
|
4/24/2014 | HY | Market Commentary: Hearthside, Centene, two add-ons price; new Hearthside bonds move up; funds gain $250 million
|
4/24/2014 | IG | Moody's might drop Zimmer notes
|
3/7/2014 | BKHY | S&P could lift Biomet
|
9/12/2013 | BK | Market Commentary: Activision, Biomet, Steinway, Capsugel break; Valeant tweaks deal; JBS books shut early
|
9/10/2013 | BK | Biomet ups term B-2 to $2.98 billion, flexes to Libor plus 350 bps
|
9/10/2013 | BK | Market Commentary: Pinnacle Foods, Photonis free up; Biomet, Go Daddy, Activision Blizzard revise deals
|
9/9/2013 | BK | Market Commentary: Neiman softens on buyout news; Biomet, Steinway revise deadlines; Nine, Pinnacle tweak deals
|
9/4/2013 | BKHY | S&P rates Biomet loan BB-
|
9/4/2013 | BKHY | Moody's rates Biomet loan B1
|
9/3/2013 | BK | Biomet to launch $865 million term loan B on Wednesday morning
|
9/3/2013 | BK | Market Commentary: Jarden, Yankee Candle dip with acquisition news; NXT reworks term B; primary calendar builds
|
7/22/2013 | BK | Market Commentary: U.S. Silica, Atlas Energy break; Gardner Denver, TridentUSA, Midcontinent revisions emerge
|
4/9/2013 | BKHY | Biomet reports $6 billion net debt at end of fiscal 2013 third quarter
|
12/17/2012 | BK | Market Commentary: Tribune, Aramark, United Surgical, CTI Foods break; Ancestry.com makes additional revisions
|
12/17/2012 | BK | Biomet increases add-on term loan to $730 million; deal prices at par
|
12/14/2012 | BK | Biomet doubles term loan add-on to $500 million, eliminates OID
|
12/14/2012 | BK | Market Commentary: Alcatel-Lucent rolls out dual-currency deal; Biomet doubles deal size; USI tightens talk
|
12/12/2012 | BK | Market Commentary: Custom Building breaks; MGM, Stallion, Heartland, Houghton, Cinemark, Nomacorc revise
|
12/12/2012 | BKDDHY | S&P: Biomet unchanged
|
12/12/2012 | BK | Biomet launches $250 million add-on term loan at discount of 991/2-993/4
|
12/11/2012 | BK | Biomet readies launch of $250 million add-on term loan for Wednesday
|
12/11/2012 | BK | Market Commentary: Spansion, MedAssets, Sidera break; SunGard, MGM shutting early; Riverbed revises deal
|
11/19/2012 | BK | Biomet closes $500 million asset-based revolving credit facility deal
|
10/10/2012 | BK | Biomet extends $393 million of U.S., €33 million of euro term loans
|
10/5/2012 | HYLM | Biomet calls $908.48 million of 10%, 11 5/8% notes following tender
|
9/19/2012 | HY | Market Commentary: Nationstar, AOT deals price, move up, Hovnanian, Intelsat also drive by; calendar swells
|
9/19/2012 | HYLM | Biomet amends 11 5/8% notes tender offer, lifts cap to $800 million
|
9/18/2012 | HY | Biomet to price $1.33 billion notes in two parts after investor call
|
9/18/2012 | HY | New Issue: Biomet prices upsized $1.63 billion eight-year notes in two parts
|
9/18/2012 | HY | Market Commentary: PDVSA bonds active, soft; FMG's new loan helps bonds, stock; Patriot Coal dips; ResCap rises
|
9/18/2012 | BKDDHY | Moody's: Biomet notes B3, Caa1
|
9/18/2012 | HYLM | Biomet offers to buy back 10% notes, up to $500 million 11 5/8% notes
|
9/18/2012 | BKHY | S&P rates Biomet notes B-
|
9/18/2012 | HY | Biomet sets price talk for $1.33 billion two-part offering of notes
|
8/16/2012 | HYLM | Biomet calls all $227.28 million 10 3/8%/11 1/8% notes due 2017
|
8/6/2012 | BK | Biomet extends $1 billion of U.S., €631 million of euro term loans
|
7/27/2012 | HY | Market Commentary: Pause marks end of $6.4 billion week; new Toys bonds firm, Aurora jumps; McClatchy up on Q2
|
7/26/2012 | HY | Market Commentary: Toys 'R' Us, Aurora drive by with upsized deals; Sprint runs up on Q2; funds jump by $2 billion
|
7/25/2012 | HY | New Issue: Biomet sells upsized $1 billion eight-year notes at par to yield 61/2%
|
7/25/2012 | HY | Market Commentary: Biomet, QR Energy, Pantry price, new Biomet better; Radio Shack routed after poor numbers
|
7/25/2012 | HYLM | Biomet starts tender for 10 3/8-11 1/8% toggle notes due 2017
|
7/25/2012 | BKHY | Moody's rates Biomet revolver B1, notes B3
|
7/25/2012 | BKHY | S&P rates Biomet notes B-
|
7/25/2012 | BKHY | S&P rates Biomet loan BB-
|
7/23/2012 | BK | Market Commentary: Party City breaks; GenOn up on NRG merger; LodgeNet falls; Windstream reveals guidance
|
7/20/2012 | BK | Biomet readies launch of term loan amendment and extension for Monday
|
7/20/2012 | BK | Market Commentary: LodgeNet plunges more on poor results; Connolly tweaks deal; Biomet plans amend, extend
|
6/6/2012 | BKHY | Moody's: Biomet unaffected
|
4/11/2012 | BKHY | Biomet ends fiscal 2012 third quarter with $5.4 billion of net debt
|
4/3/2012 | BKHY | Moody's: Biomet unaffected
|
4/3/2012 | BKHY | S&P: No change to Biomet
|
1/19/2011 | HY | Market Commentary: Inergy, Charter, Targa drive-bys pace $1.9 billion primary; Harry & David swoons on warning
|
6/17/2010 | HY | Market Commentary: Talk out on Citgo deal, Radio One shops notes; secondary firm again, funds back in the black
|
1/14/2010 | BK | Biomet paid down portion of revolver and bank borrowings in 2009
|
10/9/2009 | BK | Market Commentary: Biomet up with numbers; HealthSouth slides; Zuffa sets pricing, breaks; Skype tweaks deal
|
6/18/2009 | HY | Market Commentary: Upsized Wendy's, Quicksilver Resources deals price; SLM strengthens on contract news; funds gain $358 million
|
6/16/2009 | HY | Market Commentary: Cinemark, Limited Brands price deals; Paetec, Real Mex hit the road; overall market easier
|
5/18/2009 | BKHY | Moody's raises Biomet outlook to stable
|
4/14/2009 | BKBWHY | Biomet ends fiscal 2009 third quarter with liquidity of $953 million
|
4/8/2009 | BK | Market Commentary: Biomet up with sales numbers; GM, Visteon bid higher; cash rally continues; TNS readies allocations
|
4/8/2009 | HY | Market Commentary: Biomet gets a boost on sales numbers; Qwest bonds moving higher; GM retreats, Ford continues to gain
|
2/9/2009 | BK | Market Commentary: Secondary sees 80-type names moving higher; Landry's still fine tuning term loan discount price
|
1/13/2009 | HY | Market Commentary: Isle of Capri jumps on partial tender offer; Neiman Marcus off on PIK interest decision; Nortel baffles investors
|
10/15/2008 | BK | Biomet revolver effectively reduced by Lehman Brothers bankruptcy
|
4/15/2008 | BK | Market Commentary: Kinetic plans downsizing; SP Newsprint firms OID; Biomet up on numbers; Delta, Northwest rise
|
10/15/2007 | HY | Market Commentary: Bausch & Lomb downsizes, restructures deal; Level 3 off on CFO departure; GM gyrates
|
10/12/2007 | HY | Market Commentary: Allison Transmission prices another new deal; GM continues rise; Trump gains, housing eases
|
10/11/2007 | HY | Market Commentary: Allison deal prices, trades up, Biomet as well; Beazer up on restatement news; funds see $26 million inflow
|
10/11/2007 | HY | New Issue: Biomet prices $217 million three-part add-on
|
10/10/2007 | HY | Market Commentary: Allison pricing seen Thursday; new AES bonds move up; Fremont jumps
|
10/4/2007 | BK | Market Commentary: Biomet loan trades higher; LCDX trades flat; Metavante $2 billion bank meeting set for Tuesday
|
10/3/2007 | HY | Market Commentary: Ryerson prices two-part offering; Canadian forest product names up; Pogo up on M&A developments
|
10/2/2007 | HY | Underwriters price and hold $3.8 billion of H.D. Supply junk bonds
|
10/2/2007 | HY | Market Commentary: R.H. Donnelley taps junk market again; Dean easier on earnings warning; auto bonds ignore sales data
|
9/25/2007 | SS | Equity group completes acquisition of Biomet
|
9/25/2007 | BK | Market Commentary: Affinion unsecured loan trades up; Movie Gallery rises on store consolidation; LCDX, cash lower
|
9/25/2007 | BKHY | Moody's gives Biomet B2
|
9/25/2007 | HY | Biomet bonds trading north of bridge, a signal of junk market's health, banker says
|
9/25/2007 | HY | Market Commentary: Range prices upsized 10-year; housing names weaker after Lennar results; Unisys off on security flap
|
9/24/2007 | HY | New Issue: Biomet prices $2.35 billion of notes in three tranches
|
9/24/2007 | HY | Market Commentary: Biomet in three-part mega-deal, American Tower, Waterford also price; GM gyrates on UAW news
|
9/5/2007 | SS | Biomet shareholders approve acquisition; deal to close in September
|
7/12/2007 | BK | Market Commentary: Integra, Bisys, CEVA, Primedia, Thomas Properties, CPI set talk; Biomet, EPD, Hilite tweak deals
|
7/12/2007 | HY | Biomet expected to launch $2.565 billion bonds on Aug. 1
|
7/12/2007 | SS | Equity group completes tender offer for Biomet
|
7/11/2007 | BK | Market Commentary: Tata, GSI, Elder Health, Station set talk; Source, Biomet, AmerCable tweak deals; CanWest, Harlan break
|
6/25/2007 | SS | Farallon-investors report 5.6% stake in Biomet
|
6/22/2007 | BKHY | Moody's confirms Biomet
|
6/21/2007 | BK | Market Commentary: U.S. Foodservice, Trilogy tweak deals; Harlan, Norwood set talk; Tribune rebounds with market
|
6/13/2007 | SS | Private equity group begins tender offer for Biomet
|
6/11/2007 | BK | Market Commentary: Intertape Polymer, EPD set talk; EnergySolutions dips on new debt; Lear trades around
|
6/7/2007 | BKHY | Moody's may downgrade Biomet
|
6/7/2007 | SS | Biomet: Equity group increases offer for company; June 8 special meeting canceled
|
6/7/2007 | SS | Market Commentary: Biomet bounces; Parker, Nabors drop; Netflix flies as Amazon, Audible slip; Broadcom better
|
5/30/2007 | BK | Market Commentary: Biomet, Jacobson set talk; Liberty Cablevision, Continental tweak deals; IPC breaks; Berry Plastics dips
|
5/25/2007 | BK | Biomet $4.35 billion credit facility to launch next week
|
5/24/2007 | HY | Biomet details new $2.565 billion three-part note offering backing LBO
|
5/24/2007 | BKHY | S&P assigns Biomet B+, loans BB-, B+, notes B-
|
5/24/2007 | BKHY | Moody's rates Biomet loans Ba2, B1, notes B3, Caa1
|
5/21/2007 | BK | Biomet $4.35 billion credit facility expected as June business
|
5/17/2007 | HY | Biomet $2.565 billion bonds expected in June, Banc of America to lead
|
4/24/2007 | SS | Biomet shareholders to vote June 8 on acquisition by investor group
|
2/20/2007 | SS | Waiting period ends early for Blackstone-led acquisition of Biomet
|
1/31/2007 | BKHY | Biomet LBO financing to include $4.35 billion credit facility, $2.565 billion bonds
|
12/18/2006 | BK | Biomet gets debt financing commitment for buyout by private equity consortium
|
12/18/2006 | SS | Biomet, Icos merger deals spur action in Telik; Harrah's bets cagey; Caremark rival bid pushes Medco up
|
12/11/2006 | SS | Citigroup spikes 2%, give back half after-hours; Sabre up on buyout buzz; Phelps Dodge eases
|
11/2/2006 | BT | Market Commentary: Exelixis stock off 12% after XL999 trial suspended; ViroPharma reports $23.3 million Q3 net income
|
9/20/2006 | BT | Biomet at sector perform by RBC
|
7/28/2006 | BT | Biomet says scope of antitrust investigation narrowed
|
7/28/2006 | BT | Market Commentary: Genitope crashes; Biomet firms; Dynavax tumbles; Nymox gains; Napo debut in London next week
|
6/28/2006 | BT | Biomet fourth-quarter net sales up 7% to $540 million
|
6/28/2006 | BT | Biomet given sector perform rating by RBC
|
6/27/2006 | BT | Biomet rated at sector perform by RBC
|
5/22/2006 | BT | Cytomedix licenses patents to Biomet for $2.6 million
|
4/11/2006 | BT | Market Commentary: NitroMed, Antigenics strike new lows; NPS Pharma, Insmed gain; Medtronic deal boosts Biomet
|
4/7/2006 | BT | Market Commentary: Medarex slides; Biomet gains on anticipated sale; Cell Therapeutics higher; Acusphere dives on PIPE
|
4/6/2006 | BT | Biomet hires Morgan Stanley to help explore strategic alternatives
|
4/5/2006 | BT | Bear Stearns puts Biomet at peer perform
|
3/22/2006 | BT | Artimplant: Biomet to launch rotator cuff device in United States this week
|
3/22/2006 | BT | Biomet kept at market underperform by JMP
|
1/23/2006 | BT | Artimplant gets OK to sell rotator cuff patch in U.S.; Biomet to market product under name Sportmesh
|
1/6/2006 | BT | JMP: St. Jude, Medtronic best bets in medical device stocks; still wary of orthopedics
|
12/22/2005 | BT | Biomet maintained by JMP at underperform
|
12/21/2005 | BT | Biomet's ceramic-on-ceramic hip system receives FDA approval
|
12/21/2005 | BT | Biomet to repurchase $100 million of shares under new program
|
9/27/2005 | BT | Biomet initiated by JMP at underperform
|
6/30/2005 | BT | Biomet to buy back 2.5 million shares over 12 months
|
6/16/2005 | BT | Insamed upgraded by CE Unterberg
|